Primary tumour size is a prognostic parameter in patients suffering from differentiated thyroid carcinoma with extrathyroidal growth: results of the MSDS trial - Kramer, J A; Schmid, K W; Dralle, H (Eur J Endocrinol, 2010)
et al.